Biomaterial Technologies for Precision Medicine

Timeslot: Thursday, April 12, 2018 - 10:30am to 12:30pm
Track: Biomaterials Fabrication and Analysis
Room: 204/205


As the demand for precision medicine continues to rise, the “one size fits all” approach to the design of medical devices and therapies to treating specific diseases and injuries is becoming increasingly outdated. Biomaterials have significant potential for transforming precision medicine, and individual patient complexity often necessitates integrating multiple functions into a single device to successfully tailor personalized therapies. In this session, we seek to highlight the latest research in biomaterials based technologies that enable precision medicine, such as implantable devices for the in situ, real-time analysis of a patient’s condition or customized devices or material chemistries that adapt to a specific patient’s biology. We aim for our session to demonstrate that biomaterials-based technologies may address limitations to current approaches in precision medicine and may allow for more personalized therapies for patients.


  • 10:30 a.m. 168. Invited Speaker: Natalie Artzi, PhD, Harvard/MIT

  • 11:00 a.m. 169. Injectable, MMP-responsive hydrogels for on-demand siRNA delivery after myocardial infarction, L Wang*, J Chung, S Uman, P Atluri, J Burdick; University of Pennsylvania, Philadelphia, PA

  • 11:15 a.m. 170. Biomaterial scaffolds recruit an aggressive population of metastatic tumor cells in vivo, G. Bushnell*, T. Hardas, R. Hartfield, Y. Zhang, R. Oakes, J. Jeruss, L. Shea; University of Michigan, Ann Arbor, MI

  • 11:30 a.m. 171. Smart Contact Lens for Real-Time Glucose Monitoring and Wirelessly-Controlled Drug Delivery, S Hahn*; POSTECH, Pohang, Republic of Korea

  • 11:45 a.m. 172. Development of a High Throughput 3D Biomaterials Platform to Measure Protease Activity in Breast Cancer Patients, A. Fakhouri*(1), J. Weist(1), A. Tomusko(1), L. Yee(2), J. Leight(1); (1)The Ohio State University, Columbus, OH, (2)City of Hope, Duarte, CA

  • 12:00 noon 173. Magnetically responsive hydrogls for optimizing anticancer therpeutic delivery profiles, T Emi, T Barnes, E Orton, A Reisch, Z Silveira, A Tolouei, S Kennedy*; University of Rhode Island, Kingston, RI

  • 12:15 p.m. 174. The Molecular Signature of a Synthetic Pre-Metastatic Niche for Prediction of Metastatic Potential, R. Oakes*, G. Bushnell, J. Decker, Y. Zhang, R. Hartfield, P. LaFaire, P. Kandagatla, J. Jeruss, L. Shea; University of Michigan, Ann Arbor, MI

Invited Speaker(s)